Arkady Mandel
Vermogen: 90 876 $ op 30-06-2026
Vermogen: 90 876 $ op 30-06-2026
Arkady Mandel is currently the Director & Chief Scientific Officer at Theralase Technologies, Inc. He previously served as the Chief Executive Officer & Chief Scientific Officer at Theralase, Inc. He obtained his doctorate degree from Russian State Medical University in 1978.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 20-05-2026 | 493.889 ( 0,17% ) | 90 876 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| THERALASE TECHNOLOGIES INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2018 |
| Bedrijven | Functie | Einde |
|---|---|---|
Theralase, Inc.
Theralase, Inc. Medical SpecialtiesHealth Technology Designs and manufactures therapeutic medical laser systems | Algemeen Directeur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
Theralase, Inc.
Theralase, Inc. Medical SpecialtiesHealth Technology Designs and manufactures therapeutic medical laser systems | Health Technology |
Theralase Technologies, Inc.
Theralase Technologies, Inc. Medical SpecialtiesHealth Technology Designs, develops and manufactures super-pulsed, cold laser technology and equipment | Health Technology |
Russian State Medical University
Russian State Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau